CVS has announced the launch of CVS Pharmacy Rx Savings Finder, which will provide its 30,000 pharmacists the ability to find less expensive alternatives for their patients.
In an effort to help curb drug costs and provide more transparency, CVS is introducing a new tool to alert its pharmacists of cheaper drug options when they fill a patients’ prescriptions.
In a press release Wednesday, the company announced the launch of CVS Pharmacy Rx Savings Finder, which will provide its 30,000 pharmacists the ability to find less expensive alternatives for their patients. Pharmacists will be able to review a patient’s prescription regimen, medication history, and insurance plan information at the pharmacy counter.
Prescription drug prices remain a top concern for Americans. According to a recent national poll, commissioned by CVS Health, 83% of Americans voiced concern about the impact of rising prescription drug prices.
“Today’s consumers are faced with higher prescription drug prices than ever before, and many of them are now paying for a larger share of their prescription drug costs out of their own pockets at the pharmacy counter due to growth in high deductible health plans,” said Thomas Moriarty, chief policy and external affairs officer, CVS Health. “Until now, patients haven’t had the appropriate tools available to them to help manage these costs.”
The Savings Finder will work by sequentially alerting the pharmacist if:
The company is hoping that the program will also help with medication adherence. Kevin Hourican, executive vice president of retail pharmacy for CVS Pharmacy, noted that patients who are faced with high out-of-pocket costs at the pharmacy are less likely to pick up their prescription and are thus less likely to be adherent to their treatment regimen.
The program will first be made available to members of CVS’ pharmacy benefit manager branch, Caremark, and is expected to be rolled out more broadly throughout the year, according to Hourican.
CVS has also recently introduced a real-time benefits program to allow providers and their Caremark members to see the member-specific cost for a drug at the time of prescribing, as well as up to 5 of the lowest-cost, clinically appropriate therapeutic alternatives based on the patient’s formulary. According to the release, early results show that prescribers accessing the real-time benefits information switched their patient’s treatment from a non-covered drug to a drug on the formulary 85% of the time. When the patient’s drug was covered, prescribers switched the patient to a lower-cost alternative 30% of the time.
The launching of CVS Pharmacy Rx Savings Finder comes as the company is in the process of purchasing Aetna, with the idea of remaking the consumer healthcare experience by integrating doctors, pharmacists, and other health professionals with health benefits.
What We’re Reading: ChatGPT in Health Care; Menthol Ban Meeting; Health System Cyberattack Impact
November 30th 2023ChatGPT is changing health care while also raising questions about artificial intelligence's promises and limitations; 24 Biden officials met with the National Organization of Black Law Enforcement Executives to discuss the FDA’s proposal to ban menthol cigarettes; a recent hospital cyberattack shows how the vulnerability of health care systems can put patients at risk.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More